{"id":154,"date":"2023-04-27T16:13:00","date_gmt":"2023-04-27T14:13:00","guid":{"rendered":"https:\/\/aplusa.local\/?p=154"},"modified":"2026-02-03T17:19:29","modified_gmt":"2026-02-03T16:19:29","slug":"ssml-4-focus-on-patients-during-multiple-myeloma-awareness-month","status":"publish","type":"post","link":"https:\/\/www.aplusaresearch.com\/fr\/perspectives\/ssml-4-focus-on-patients-during-multiple-myeloma-awareness-month\/","title":{"rendered":"Le SSML #4 se concentre sur les patients pendant le mois de sensibilisation au my\u00e9lome multiple"},"content":{"rendered":"
L'objectif de cette lettre d'information est de donner un aper\u00e7u de ce qui se passe autour du my\u00e9lome multiple en termes de d\u00e9veloppements m\u00e9dicaux. Pour ce faire, nous suivons d'une part les articles de presse, les communiqu\u00e9s de presse et les rapports scientifiques. D'autre part, les conversations des professionnels de la sant\u00e9, des leaders d'opinion num\u00e9riques et d'autres influenceurs qui assistent aux congr\u00e8s, donnent leur avis sur les traitements et commentent les nouveaux d\u00e9veloppements.<\/p>\n\n\n\n
Objectifs<\/h2>\n\n\n\n
Qui b\u00e9n\u00e9ficiera de cette lettre d'information ?<\/p>\n\n\n\n
Tous les professionnels souhaitant se tenir au courant des d\u00e9veloppements concernant le my\u00e9lome multiple :<\/p>\n\n\n\n
\n
Les sp\u00e9cialistes du marketing<\/li>\n\n\n\n
Analystes d'entreprise<\/li>\n\n\n\n
Mais aussi les professionnels de la sant\u00e9 qui souhaitent anticiper le paysage futur de la prise en charge du MM.<\/li>\n<\/ul>\n\n\n\n
Champ d'application<\/h2>\n\n\n\n
L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n
Il y a eu un total de 28K mentions de patients enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute du 1er mars 2023 au 31 mars 2023.<\/p>\n\n\n\n
La majorit\u00e9 des mentions proviennent de Twitter (42%), News (40%), Instagram (13%), Forums (2%), Reddit (1%), Blogs (1%), et tumblr (1%).<\/p>\n\n\n\n
Au total, 6 000 auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n
: My\u00e9lome OR multiplemyeloma OR #Mmsm OR #Myeloma OR #Curemyeloma* OR #Mmmrd OR #mmsm OR title : (\"multiple myeloma\" OR myeloma)<\/p>\n\n\n\n
M\u00e9thodologie<\/h2>\n\n\n\n<\/figure>\n\n\n\n
Quelques extraits du SMML<\/h2>\n\n\n\n
Le mois de la sensibilisation au MM met l'accent sur les patients<\/h3>\n\n\n\n<\/figure>\n\n\n\n
Sujet de discussion<\/h3>\n\n\n\n<\/figure>\n\n\n\n<\/figure>\n\n\n\n
D\u00e9couvrez l'int\u00e9gralit\u00e9 de la lettre d'information avec des verbatims suppl\u00e9mentaires, les articles les plus lus, ainsi que la veille sur le march\u00e9 des m\u00e9dicaments.<\/p>","protected":false},"excerpt":{"rendered":"
The goal of this newsletter is to give an overview of what is happening around multiple myeloma in terms of medical developments. This is achieved by monitoring news articles, PR releases and scientific reports on one hand. Conversations from HCPs, digital opinion leaders and other influencers attending congresses, offering their opinion on treatments and commenting […]<\/p>\n","protected":false},"author":4,"featured_media":7076,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"Track global multiple myeloma developments with insights from news, PRs, science, and HCP voices: trends, verbatims, and drug market watch.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-154","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=154"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/154\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/7076"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/promo-reseaux-sociaux.webp\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/promo-reseaux-sociaux-1.webp\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/sans-titre-12-1-1024x415.webp\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/sans-titre-13-1024x504.avif\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/1-apr-26-2023-08-30-50-0806-am-1024x415.webp\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/04\/2-apr-26-2023-08-30-54-2626-am-1024x415.webp\")
<\/figure>\n\n\n\n